Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

146.67
Delayed Data
As of 4:00pm ET
 +4.16 / +2.92%
Today’s Change
124.16
Today|||52-Week Range
208.88
-23.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line170.2M-183.8M66.6M92.2M
 
 
 
 
 
Depreciation12.6M49.7M87.4M96.8M
 
 
 
 
 
Total Other Cash Flow102.3M171.1M108.5M40.6M
 
 
 
 
 
Funds From Operations306.3M426.5M272.0M258.9M
 
 
 
 
 
Funds From/For Other Operating Expenses68.1M203.4M81.2M90.9M
 
 
 
 
 
Net Cash Flow - Operating Activities238.2M223.1M190.9M168.0M
 
 
 
 
 
 
InvestingIncrease In Investments-22.6M-193.6M-149.9M-211.0M
 
 
 
 
 
Decrease In Investments854.6M70.4M68.4M269.5M
 
 
 
 
 
Capital Expenditures-73.1M-76.1M-80.1M-64.2M
 
 
 
 
 
Net Assets From Acquisitions -3.9B-39.0K0.000.00
 
 
 
Other Investing - Sources459.0K4.1M-5.0K82.0K
 
 
 
 
 
Net Cash Flow Investing-3.2B-195.2M-161.6M-5.7M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings3.7B0.000.000.00
 
 
Long Term Debt Reduction-245.5M0.00-43.8M-175.0M
 
 
 
 
Net Proceeds Stock Sale6.8M19.1M27.1M9.4M
 
 
 
 
 
Common Preferred Redeemed-23.5M-91.8M-152.3M-296.5M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing-41.8M15.2M0.000.00
 
 
 
Other Uses - Financing4.2M127.6M12.3M4.1M
 
 
 
 
 
Net Cash Flow - Financing3.3B-185.0M-181.3M-466.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash712.0K-1.7M-1.1M4.0M
 
 
 
 
 
 
Net Change In Cash404.6M-157.1M-152.0M-303.9M